Researchers at MIT, the Ragon Institute of MIT, Massachusetts General Hospital, and Harvard University are working on strategies for designing a universal flu vaccine that could work against any flu strain. In a new study, they describe a vaccine that triggers an immune response against an influenza protein segment that rarely mutates but is normally not targeted by the immune system. The vaccine consists of nanoparticles coated with flu proteins that train the immune system to create the desired antibodies.
An official website of the United States government.